Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study-Reference-Cited by-同舟云学术

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study

Published:2024-04 Issue:4 Volume:24 Page:427-436
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Cooper Laura V,Erbeto Tesfaye B,Danzomo Abba A,Abdullahi Hamisu W,Boateng Kofi,Adamu Usman S,Shuaib Faisal,Modjirom Ndoutabe,Gray Elizabeth J,Bandyopadhyay Ananda S,Zipursky Simona,Okiror Samuel O,Grassly Nicholas C,Blake Isobel M

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Reference23 articles.

1. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus;Kew;Science,2002

2. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine;Macklin;Science,2020

3. Engineering the live-attenuated polio vaccine to prevent reversion to virulence;Yeh;Cell Host Microbe,2020

4. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials;Sáez-Llorens;Lancet,2021

5. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study;Mangal;Lancet Glob Health,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024;Pathogens;2024-05-22

2. Novel oral poliovirus vaccine type 2 is an important eradication tool, but reaching every last child remains vital;The Lancet Infectious Diseases;2024-04

3. Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study;The Lancet Infectious Diseases;2024-04

4. Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency;Pathogens;2024-03-23

5. Circulating vaccine derived polio virus type 2 outbreak and response in Yemen, 2021–2022, a retrospective descriptive analysis;BMC Infectious Diseases;2024-03-15